Prevention of thromboembolism induced by prosthetic heart valves.
Fuster
V
V
Division of Cardiology, Mount Sinai Medical Center, New York, NY 10029.
Badimon
L
L
Badimon
J J
JJ
Chesebro
J
J
D001021:Aortic Valve; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008943:Mitral Valve; D011474:Prosthesis Design; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents